Você pesquisou por y - Revista Brasileira de Ginecologia e Obstetrícia
You searched for:"Marise Amaral Rebouças Moreira"
We found (3) results for your search.Summary
Rev Bras Ginecol Obstet. 2000;22(5):307-310
DOI 10.1590/S0100-72032000000500009
Polymastia is a usual problem in Mastology clinics and the possibility of cancer must be taken into consideration, as much as in any other mammary tissue. In the present study the case of a 48-year-old patient, submitted to the excision of the left axillary breast for cosmetic purposes is reported. The histological examination showed an invasive ductal carcinoma with an extensive in situ component. The patient was submitted to a wide excision plus axillary lymphadenectomy and radiation therapy. The frequency, diagnosis, prognosis and treatment of cancer in supernumerary breasts is also reviewed.
Summary
Rev Bras Ginecol Obstet. 2000;22(5):307-310
DOI 10.1590/S0100-72032000000500009
Polymastia is a usual problem in Mastology clinics and the possibility of cancer must be taken into consideration, as much as in any other mammary tissue. In the present study the case of a 48-year-old patient, submitted to the excision of the left axillary breast for cosmetic purposes is reported. The histological examination showed an invasive ductal carcinoma with an extensive in situ component. The patient was submitted to a wide excision plus axillary lymphadenectomy and radiation therapy. The frequency, diagnosis, prognosis and treatment of cancer in supernumerary breasts is also reviewed.
Summary
Rev Bras Ginecol Obstet. 2018;40(7):410-416
To estimate the cytological and colposcopic performances for the diagnosis of cervical neoplasias.
Cross-sectional retrospective study with data from patients’ charts. The participants underwent colposcopy, guided biopsies, and excision when needed. The cytological and colposcopic categorization followed the Bethesda System and the international colposcopic terminologies. The cytology and colposcopy performances were evaluated by sensitivity (SE), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) analyses with 95% confidence interval (95% CI).
From 1,571 participants, a total of 1,154 (73.4%) were diagnosed with cervical squamous intraepithelial neoplasia grade 2 or worse (CIN 2+), 114 (7.2%) with adenocarcinoma in situ or worse (AIS+), 615 (39.2%) presented atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion or worse (ASC-H+) cytology, and 934 (59.4%) presented major or suspicious for invasion colposcopic abnormalities. The SE, SP, PPV, and NPV of ASC-H+ for diagnoses of CIN 2+ and AIS+ were, respectively: 44% (95% CI: 41-47) and 72% (95% CI: 67-76), 79% (95% CI: 77-81) and 79% (95% CI: 75-83), 88% (95% CI: 87-90) and 55% (95% CI: 50-60), and 28% (95% CI: 26-31) and 88% (95% CI: 85-91). The SE, SP, PPV, and NPV of major or suspicious for invasion colposcopic abnormalities for diagnoses of CIN 2+ and AIS+were, respectively: 62% (95% CI: 60-65) and 86% (95% CI: 83-89), 59% (95% CI: 57-62) and 59% (95% CI: 55-64), 85% (95% CI: 83-87) and 44% (95% CI: 40-49), and 29% (95% CI: 27-32) and 92% (95% CI: 89-94).
The SE analyses results of ASC-H+ and major or suspicious for invasion colposcopic abnormalities were higher for diagnoses of glandular neoplasias. These results confirm the role of cytology in identifying women at risk who will have their final diagnoses settled by colposcopy and histology.
Summary
Rev Bras Ginecol Obstet. 2018;40(7):410-416
To estimate the cytological and colposcopic performances for the diagnosis of cervical neoplasias.
Cross-sectional retrospective study with data from patients’ charts. The participants underwent colposcopy, guided biopsies, and excision when needed. The cytological and colposcopic categorization followed the Bethesda System and the international colposcopic terminologies. The cytology and colposcopy performances were evaluated by sensitivity (SE), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) analyses with 95% confidence interval (95% CI).
From 1,571 participants, a total of 1,154 (73.4%) were diagnosed with cervical squamous intraepithelial neoplasia grade 2 or worse (CIN 2+), 114 (7.2%) with adenocarcinoma in situ or worse (AIS+), 615 (39.2%) presented atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion or worse (ASC-H+) cytology, and 934 (59.4%) presented major or suspicious for invasion colposcopic abnormalities. The SE, SP, PPV, and NPV of ASC-H+ for diagnoses of CIN 2+ and AIS+ were, respectively: 44% (95% CI: 41-47) and 72% (95% CI: 67-76), 79% (95% CI: 77-81) and 79% (95% CI: 75-83), 88% (95% CI: 87-90) and 55% (95% CI: 50-60), and 28% (95% CI: 26-31) and 88% (95% CI: 85-91). The SE, SP, PPV, and NPV of major or suspicious for invasion colposcopic abnormalities for diagnoses of CIN 2+ and AIS+were, respectively: 62% (95% CI: 60-65) and 86% (95% CI: 83-89), 59% (95% CI: 57-62) and 59% (95% CI: 55-64), 85% (95% CI: 83-87) and 44% (95% CI: 40-49), and 29% (95% CI: 27-32) and 92% (95% CI: 89-94).
The SE analyses results of ASC-H+ and major or suspicious for invasion colposcopic abnormalities were higher for diagnoses of glandular neoplasias. These results confirm the role of cytology in identifying women at risk who will have their final diagnoses settled by colposcopy and histology.
Summary
Rev Bras Ginecol Obstet. 2001;23(10):635-639
DOI 10.1590/S0100-72032001001000004
Purpose: to analyze the factors that may be related to insufficient material in fine needle aspiration cytology (FNAC). Patients and Methods: a total of 351 FNAC of patients with solid breast tumors were studied in a random way: 180 (51%) by Cameco's pistol holder and 171 (49%) by the auto-vacuum device. All smears were analyzed by only one cytopathologist, and they were described as malignant, suspicious, benign or insufficient for diagnosis. The significance of each variable was tested by the c² test. Results: among the 351 cases analyzed, we found 67 (19%) of insufficient material. The device used (pistol or auto-vacuum), the size of the tumor and the clinical stage of the lesions were not related to the frequency of sufficient and insufficient material. The age of the patient and the histological type of the tumor were related to the rate of insufficient material. Patients younger than 50 had a 12% rate of insufficient material, compared to 30 above 50 (p<0.03). The patients with fibroadenosis had a rate of 30%, those with ductal carcinoma, 20%, and those with fibroadenoma 12% (p<0.02). Conclusion: the present study showed a relatively high rate of insufficient material (19%), which was influenced by the age of the patient and the histological type of the biopsied breast lesion.
Summary
Rev Bras Ginecol Obstet. 2001;23(10):635-639
DOI 10.1590/S0100-72032001001000004
Purpose: to analyze the factors that may be related to insufficient material in fine needle aspiration cytology (FNAC). Patients and Methods: a total of 351 FNAC of patients with solid breast tumors were studied in a random way: 180 (51%) by Cameco's pistol holder and 171 (49%) by the auto-vacuum device. All smears were analyzed by only one cytopathologist, and they were described as malignant, suspicious, benign or insufficient for diagnosis. The significance of each variable was tested by the c² test. Results: among the 351 cases analyzed, we found 67 (19%) of insufficient material. The device used (pistol or auto-vacuum), the size of the tumor and the clinical stage of the lesions were not related to the frequency of sufficient and insufficient material. The age of the patient and the histological type of the tumor were related to the rate of insufficient material. Patients younger than 50 had a 12% rate of insufficient material, compared to 30 above 50 (p<0.03). The patients with fibroadenosis had a rate of 30%, those with ductal carcinoma, 20%, and those with fibroadenoma 12% (p<0.02). Conclusion: the present study showed a relatively high rate of insufficient material (19%), which was influenced by the age of the patient and the histological type of the biopsied breast lesion.